Northside Hospital’s Blood and Marrow Transplant (BMT) Program has again ranked among the best in the United States for bone marrow transplant survival outcomes.
For the 16th consecutive year (2009-24), Northside’s program exceeded predicted one-year survival outcomes for U.S. transplant centers, according to the 2024 Transplant Center Survival Report by the Centers for International Blood and Marrow Transplant Research (CIBMTR).
- Northside is the only U.S. transplant program to achieve this historic milestone.
The big picture: Every three or four minutes, someone in the U.S. is diagnosed with a blood cancer like leukemia, according to NMDPSM (formerly Be The Match®). For many patients, their only hope for a cure is a blood or marrow transplant.
By the numbers: Each year, CIBMTR analyzes survival data for U.S. transplant centers performing allogeneic transplants, providing an overall risk-adjusted analysis indicating whether one-year survival is as expected, above expected or below expected for each specific transplant center compared to an average transplant center.
- CIBMTR’s 2024 report tabulated patient survival following transplantation at 172 adult and pediatric transplant centers for the reporting cycle of Jan. 1, 2020-Dec. 31, 2022.
- Patients at Northside had an 82.6% one-year survival rate, placing the program in the top 95th percentile for risk-adjusted survival outcomes.
- Northside operates the largest allogeneic BMT center in Georgia and one of the largest in the Southeast.
- It’s also the only center in Georgia to achieve outcomes statistically superior to predicted rates, and one of just 12 U.S. centers (less than 10% of all centers) to earn this designation in the latest reporting cycle.
What they’re saying:
- Dr. Kent Holland, Northside’s BMT program director: “Northside BMT’s survival results are unprecedented in the field of hematopoietic stem cell transplant and are the result of exceptional patient-focused quality of care.”
- Dr. Asad Bashey, director of clinical research for Northside’s BMT Program: “Northside’s BMT Program has shown, once again, that its achievement of the very best survival results possible following allogeneic transplantation is not a fluke but a result of extraordinary investment over nearly two decades to processes and practices that produce such results.”
- Jack Miller, a leukemia survivor treated at Northside: “My family put their faith in Northside’s BMT program because of its incredible reputation; if you need high-quality care in Georgia, it’s available here.”
